Table 1.
Demographic and medical characteristics of participants (n=83)
| Variable | Statistic |
|---|---|
| Age (years)a | 45 (7.7) [27-62] |
| Ethnicity | |
| Caucasian | 52% |
| African American | 39% |
| Other | 9% |
| Sex (% Men) | 83% |
| Self-Reported Duration of HIV Disease (months)a | 133 (74) [7-285] |
| Antiretroviral Therapy Use (% Currently Taking) | 78% |
| AIDS (%) | 67% |
| Current CD4+ T-cell Count (cells/mm3)b | 462 [339, 602] |
| Nadir CD4+ T-cell Count (cells/mm3)b | 147 [24, 256] |
| Plasma HIV RNA (% <50 c/mL) | 51% |
| CSF HIV RNA (% <50 c/mL) | 68% |
| HAND (%) | 37% |
| ANI | 25% |
| MND/HAD | 12% |
| HCV seropositive | 22% |
a
mean (standard deviation) [range]
b
median [interquartile range]
AIDS = acquired immunodeficiency syndrome; ANI = asymptomatic neurocognitive impairment; CSF = cerebrospinal fluid; HAD = HIV-associated dementia; HCV = hepatitis C virus; MND = mild neurocognitive disorder; RNA = ribonucleic acid.